[Today's Market Call] LG Innotek, Celltrion, HD Hyundai Electric, Hanwha Ocean, ST Pharm, Sung Kwang Bend and others
Predicted impact: Low
Broker call roundup repeating earlier target price and earnings news.
Celltrion셀트리온
068270 · KOSPI · ₩CELLTRION · 셀트리온
₩188,600▼ ₩1,400 (0.74%)End-of-day · Oct 27, 2026 · End-of-day prices.
[Today's Stock] Celltrion with record earnings · SpaceX · robot 'Almec' in focus
Predicted impact: Medium
Record quarterly earnings, but already reported and target raises covered in last 14 days.
Celltrion Hits Record Q3 Earnings on New Biosimilars
Predicted impact: Medium
Record Q3 earnings were already reported and repeated across several brokerage notes.
Celltrion Posts Record Earnings on New Product Growth; Brokerages Raise Target Prices Across the Board
Predicted impact: Medium
Record earnings and target price hikes already covered repeatedly in recent days; adds little new.
Celltrion raises target price on third straight 'earnings surprise' [Why Bio]
Predicted impact: Medium
Third straight earnings beat with raised target price; size vs revenue unclear.
Celltrion offers higher profitability than peers; re-rating expected - NH
Predicted impact: Low
Target price raise and profit outlook repeat earlier broker notes.
Celltrion target price raised to ₩270,000 on sustained new product growth
Predicted impact: Low
Target price raised on new product growth; similar broker notes already in past 14 days.
KIWOOM Securities: "Celltrion's new products to improve profitability; expects Q4 operating profit of ₩600B"
Predicted impact: Low
Broker profit forecast and target raise already reported this period.
Celltrion: Biosimilar new product sales expand; target price up 11% - NH
Predicted impact: Medium
Record quarterly revenue and target price raised 11%; meaningful but smaller than a major surprise.
After Consecutive US Competitor Approvals, Celltrion's ₩770B New Drug: Can It Overcome Late-Mover Limits?
Predicted impact: Low
Analysis piece on late-mover challenges for a new drug; no filing, approval or size data given.
Celltrion Signs Exclusive Supply Deals for Omlyclo and Aptozma in the US
Predicted impact: Medium
US exclusive supply deals for two biosimilars; contract size not disclosed, likely meaningful for revenue.
Samsung Biologics, Celltrion Hit Record Q3 Results, Intensifying Revenue Race
Predicted impact: Medium
Record Q3 results for a large biotech peer; read-across news with no direct size for this company.
[BioS] Celltrion Q3 revenue ₩1.5755T, operating profit ₩525.3B
High impactPredicted impact: High
Record Q3 results, revenue up 53% year on year; already reported repeatedly, so lowered one level.
Celltrion Posts Record Quarterly Revenue, Operating Profit in Third Quarter
Predicted impact: Medium
Q3 record results already reported (operating profit ₩525.3B, revenue up 53%), so impact lowered.
Celltrion Q3 confirmed results better than expected; operating profit ₩525.3B record high despite higher investment
Predicted impact: Medium
Confirmed quarterly results beat preliminary expectations despite higher investment spending.
Celltrion Q3 revenue and operating profit hit record highs (comprehensive)
Predicted impact: Low
Record quarterly sales and profit; the same results were already reported.
Celltrion Q3 revenue ₩1.5755T, up 53% year on year
Predicted impact: Low
Revenue up 53% year on year; the same quarterly results were already reported.
Celltrion Q3 operating profit at ₩525.3B, 'record high'; new products nearing ₩1T
Predicted impact: Medium
Record quarterly operating profit up 74% year on year; figures already reported as preliminary.
Celltrion Q3 operating profit at ₩525.3B, up 74.3% year on year
Predicted impact: Medium
Q3 operating profit up 74.3%; preliminary results already reported; extra ₩100B buyback is about 0.2% of market value.
[Major Disclosures of the Previous Day] SK hynix, Celltrion, Kukdo Chemical, Namhae Chemical, LS Eco Energy and others
Predicted impact: Low
Daily disclosure roundup; LS Eco Energy's Vietnam ₩65B investment already reported.
Also known as: Celltrion / 셀트리온 / 068270 / KRX:068270
Source: KRX statistical information